SP
Silo Pharma, Inc.
SEC filingPharmaceuticals · Sarasota, FL
Amount raised$4Msold at filing
Total offering$4M
Investors in the raise4count reported to the SEC
FiledJul 14, 2026first sale Jul 9, 2026
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Wayne LinsleyDirector
Daniel RyweckExecutive Officer
Eric WeisblumExecutive Officer, Director
Kevin MunozDirector
Jeff PavellDirector
Executive officers, directors and promoters as listed on the Form D.